A new colon cancer study from Pfizer is revealing that a combination of medications can potentially cut the risk of death in ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in ...

Creatine supplements demonstrated a hint of promise for people with Alzheimer's disease in the pilot CABA trial. In the ...

New research suggests that sitting can lead to brain shrinkage and cognitive decline, even if you regularly exercise.

John Foster, 83, managing partner of the $800 million private equity firm HealthPointCapital, made the stunning, unprompted ...

In a major study of 2.5million people, British experts discovered that suffering the problem your 40s and 50s increases the ...

Women are at the center of a health crisis. As of March 2024, the Alzheimer's Association reported 60 percent of individuals ...

The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...

More than $300 million in grant money promised to UCI, UCLA, USC and dozens of other California institutions has been axed ...

Early use of lecanemab by Medicare beneficiaries with Alzheimer’s or mild cognitive impairment is marked by racial, ethnic, ...

Researchers propose a framework for using human-based organoids to advance personalized medicine and improve Alzheimer’s ...

A new study published in The Journal of Evidence-Based Dental Practice found a strong association between periodontitis and ...